# Orbital Exenteration in Maxillary Osteosarcoma: A Case Report

**Authors:** Sannareddy Pavan Krishna Reddy, Stephen Sudhakar

PMC · DOI: 10.7759/cureus.98271 · Cureus · 2025-12-01

## TL;DR

A rare case of maxillary osteosarcoma with orbital involvement was successfully treated with surgery and chemotherapy, highlighting the importance of early diagnosis and multidisciplinary care.

## Contribution

This case report presents a rare presentation of maxillary osteosarcoma with orbital extension and emphasizes the need for radical surgical intervention.

## Key findings

- Orbital extension of maxillary osteosarcoma is rare and aggressive, requiring radical surgical resection.
- The patient remained disease-free at six months following surgery and adjuvant chemotherapy.
- Comprehensive imaging and histopathological confirmation are essential for accurate diagnosis.

## Abstract

Maxillary osteosarcoma is a rare malignant bone tumor of the craniofacial skeleton, accounting for a small proportion of head and neck sarcomas. Orbital involvement is exceptionally uncommon and poses significant diagnostic and therapeutic challenges. Early recognition and multidisciplinary management are critical for optimizing outcomes. A 41-year-old male presented with progressive nasal obstruction for one month and left eye vision loss for 20 days. Examination revealed a cystic mass in the left nasal cavity, a proliferative lesion on the hard palate, and left eye proptosis with complete visual loss. Imaging demonstrated a mass arising from the left maxillary sinus with erosion of the orbital floor and optic nerve compression. Initial biopsy suggested a chondro-osseous respiratory epithelial hamartoma. Due to the lesion’s aggressive behavior and irreversible vision loss, the patient underwent left total maxillectomy with orbital exenteration and elective tracheostomy. Final histopathology confirmed conventional osteosarcoma, grade 3 (poorly differentiated/high-grade). Adjuvant chemotherapy with cisplatin and doxorubicin was administered. At the six-month follow-up, the patient remained disease-free, with no evidence of local recurrence or distant metastasis. Orbital extension of maxillary osteosarcoma is a rare and aggressive presentation. High clinical suspicion, comprehensive imaging, and histopathological confirmation are essential for diagnosis. Radical surgical resection, including orbital exenteration when indicated, combined with adjuvant chemotherapy, is critical for achieving oncologic clearance. Multidisciplinary management is key to improving outcomes in these complex cases.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033), doxorubicin (PubChem CID 31703)
- **Diseases:** osteosarcoma (MONDO:0002623)

## Full-text entities

- **Diseases:** bone tumor (MESH:D001859), vision loss (MESH:D014786), proliferative lesion (MESH:D009059), nasal obstruction (MESH:D015508), proptosis (MESH:D005094), chondro-osseous respiratory epithelial hamartoma (MESH:D009375), head and neck sarcomas (MESH:D006258), Maxillary Osteosarcoma (MESH:D012516)
- **Chemicals:** cisplatin (MESH:D002945), doxorubicin (MESH:D004317)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12755963/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12755963/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12755963/full.md

---
Source: https://tomesphere.com/paper/PMC12755963